IPSEY:OTCMKTS
Ipsen ADR Rep 1/4 Ord Shs
40,15 USD
0,00%
(0,00) 1D
8-окт., 14:51:51 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IPSEY...
Mkt. cap
11,97 млд
Avg. vol.
1,39 миң
Volume
28,00
52-wk high
51,10 USD
52-wk low
32,68 USD
Beta
0,41
Shares outstanding
335,26 млн
No. of employees
6 миң
Mkt. cap
11,97 млд
Avg. vol.
1,39 миң
Volume
28,00
52-wk high
51,10 USD
52-wk low
32,68 USD
Beta
0,41
Shares outstanding
335,26 млн
No. of employees
6 миң
News stories
From web sources and news partners
marketscreener.com
·
36 мүнөт мурун
IT Tech Packaging Gets NYSE Extension for Delayed SEC Filings
Endpoints News
·
50 мүнөт мурун
City Therapeutics targets $158M IPO; Iambic seeks $135M Nasdaq debut
Simply Wall Street
·
6 мүнөт мурун
Leadership Expansion Might Change The Case For Investing In Warner Music Group (WMG)
Seeking Alpha
·
26 мүнөт мурун
A Correction May Be Coming, But Do Not Freak Out
Profile
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen, founded by Henri Beaufour in 1929, has approximately 5000 employees worldwide. Ipsen's medicines are registered in 88 countries with direct commercial presence in over 30 countries. Ipsen has 4 global R&D hubs and 3 pharmaceutical development centers around the world. Ipsen has been a family-owned business for the past 90 years and is publicly traded on the Euronext Paris as part of the SBF 120 index. The Beaufour family owns 57% of its shares and 73% of its voting rights, and two of its members, Anne Beaufour and Henri Beaufour, sit on its board of directors. Wikipedia
About Ipsen ADR Rep 1/4 Ord Shs